v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
1 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2019
OPERATING EXPENSES    
General and administrative expenses $ 28,393 $ 9,095,674
Research and development expenses 12,819 4,273,318
Research and development expense- licenses acquired   12,967,415
TOTAL OPERATING EXPENSES 41,212 26,336,407
LOSS FROM OPERATIONS (41,212) (26,336,407)
OTHER EXPENSE    
Interest expense (740) (128,951)
Change in fair value of warrant liabilities   (492,889)
Total other expenses (740) (621,840)
NET LOSS $ (41,952) $ (26,958,247)
BASIC AND DILUTED LOSS PER SHARE $ (0.01) $ (3.26)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
BASIC AND DILUTED 5,727,090 8,271,707

Source